| Year |
Citation |
Score |
| 2016 |
Connors JM, Klimo P, Adams G, Burns BF, Cooper I, Meyer RM, O'Reilly SE, Pater J, Quirt I, Sadura A, Shustik C, Skillings J, Sutcliffe S, Verma S, Yoshida S, ... Zee B, et al. Treatment of Advanced Hodgkin's Disease With Chemotherapy—Comparison of MOPP/ABV Hybrid Regimen With Alternating Courses of MOPP and ABVD Journal of Clinical Oncology. DOI: 10.1200/Jco.1997.15.7.2762 |
0.309 |
|
| 2007 |
Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, Lai M, Ho R, Cheung KY, Yu BK, Chiu SK, Choi PH, Teo PM, Kwan WH, Chan AT. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4873-9. PMID 17971582 DOI: 10.1200/Jco.2007.11.5501 |
0.35 |
|
| 2007 |
Ho SC, Chan AS, Ho YP, So EK, Sham A, Zee B, Woo JL. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause (New York, N.Y.). 14: 489-99. PMID 17308499 DOI: 10.1097/Gme.0B013E31802C4F4F |
0.303 |
|
| 2007 |
Mok TS, Yeo W, Johnson PJ, Hui P, Ho WM, Lam KC, Xu M, Chak K, Chan A, Wong H, Mo F, Zee B. A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 18: 768-74. PMID 17229769 DOI: 10.1093/Annonc/Mdl465 |
0.341 |
|
| 2007 |
Yeo W, Boyer M, Chung HC, Ong SY, Lim R, Zee B, Ma B, Lam KC, Mo FK, Ng EK, Ho R, Clarke S, Roh JK, Beale P, Rha SY, et al. Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG). Cancer Chemotherapy and Pharmacology. 59: 295-300. PMID 16783579 DOI: 10.1007/S00280-006-0270-1 |
0.308 |
|
| 2006 |
Leung SF, Zee B, Ma BB, Hui EP, Mo F, Lai M, Chan KC, Chan LY, Kwan WH, Lo YM, Chan AT. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 5414-8. PMID 17135642 DOI: 10.1200/Jco.2006.07.7982 |
0.319 |
|
| 2006 |
Teo PM, Leung SF, Tung SY, Zee B, Sham JS, Lee AW, Lau WH, Kwan WH, Leung TW, Chua D, Sze WM, Au JS, Yu KH, O SK, Kwong D, et al. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 79: 27-33. PMID 16626829 DOI: 10.1016/J.Radonc.2006.03.012 |
0.344 |
|
| 2006 |
Chung HC, Yeo W, Rha SY, Boyer M, Ong SY, Lim R, Zee B, Roh JK, Goh BC, Chan AT. Phase II study of irofulven in recurrent or metastatic gastric cancer: A Cancer Therapeutic Research Group (CTRG) study Journal of Clinical Oncology. 24: 14105-14105. DOI: 10.1200/Jco.2006.24.18_Suppl.14105 |
0.313 |
|
| 2005 |
Yeo W, Mok TS, Zee B, Leung TW, Lai PB, Lau WY, Koh J, Mo FK, Yu SC, Chan AT, Hui P, Ma B, Lam KC, Ho WM, Wong HT, et al. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. Journal of the National Cancer Institute. 97: 1532-8. PMID 16234567 DOI: 10.1093/Jnci/Dji315 |
0.364 |
|
| 2005 |
Mok TS, Lam KC, Lee C, Zhang L, Wong H, Chan AT, Yeo W, Yim AP, Chak K, Zee B. Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer. Oncology. 68: 485-92. PMID 16020979 DOI: 10.1159/000086992 |
0.319 |
|
| 2005 |
Davis AM, O'Sullivan B, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Hammond A, Benk V, Kandel R, Goddard K, Freeman C, Sadura A, Zee B, Day A, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 75: 48-53. PMID 15948265 DOI: 10.1016/J.Radonc.2004.12.020 |
0.319 |
|
| 2004 |
Bezjak A, Tu D, Bacon M, Osoba D, Zee B, Stuart G, Roy JA, Piccart M, Eisenhauer E. Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4595-603. PMID 15466785 DOI: 10.1200/Jco.2004.08.080 |
0.356 |
|
| 2004 |
Chan AT, Ma BB, Lo YM, Leung SF, Kwan WH, Hui EP, Mok TS, Kam M, Chan LS, Chiu SK, Yu KH, Cheung KY, Lai K, Lai M, Mo F, ... ... Zee B, et al. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3053-60. PMID 15284255 DOI: 10.1200/Jco.2004.05.178 |
0.355 |
|
| 2004 |
Hui EP, Leung SF, Au JS, Zee B, Tung S, Chua D, Sze WM, Law CK, Leung TW, Chan AT. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Cancer. 101: 300-6. PMID 15241827 DOI: 10.1002/Cncr.20358 |
0.363 |
|
| 2004 |
Yeo W, Chan PK, Ho WM, Zee B, Lam KC, Lei KI, Chan AT, Mok TS, Lee JJ, Leung TW, Zhong S, Johnson PJ. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 927-34. PMID 14990649 DOI: 10.1200/Jco.2004.05.161 |
0.342 |
|
| 2003 |
Piccart MJ, Bertelsen K, Stuart G, Cassidy J, Mangioni C, Simonsen E, James K, Kaye S, Vergote I, Blom R, Grimshaw R, Atkinson R, Swenerton K, Tropé CG, Nardi M, ... ... Zee B, et al. Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer International Journal of Gynecological Cancer. 13: 144-148. PMID 14656271 DOI: 10.1111/J.1525-1438.2003.13357.X |
0.363 |
|
| 2003 |
Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. Cancer. 98: 288-91. PMID 12872347 DOI: 10.1002/Cncr.11496 |
0.342 |
|
| 2002 |
Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M, Ho S, Huang DP, Johnson PJ. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. Journal of the National Cancer Institute. 94: 1614-9. PMID 12419787 DOI: 10.1093/Jnci/94.21.1614 |
0.325 |
|
| 2002 |
O'Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, Pater J, Zee B. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 359: 2235-41. PMID 12103287 DOI: 10.1016/S0140-6736(02)09292-9 |
0.305 |
|
| 2002 |
Leung TW, Tang AM, Zee B, Lau WY, Lai PB, Leung KL, Lau JT, Yu SC, Johnson PJ. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer. 94: 1760-9. PMID 11920539 DOI: 10.1002/Cncr.10384 |
0.342 |
|
| 2002 |
Leung TW, Tang AM, Zee B, Yu SC, Lai PB, Lau WY, Johnson PJ. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy. Cancer. 94: 421-7. PMID 11905412 DOI: 10.1002/Cncr.10236 |
0.353 |
|
| 2002 |
Roche K, Paul N, Smuck B, Whitehead M, Zee B, Pater J, Hiatt MA, Walker H. Factors affecting workload of cancer clinical trials: results of a multicenter study of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 545-56. PMID 11786585 DOI: 10.1200/Jco.20.2.545 |
0.358 |
|
| 2001 |
Dent S, Zee B, Dancey J, Hanauske A, Wanders J, Eisenhauer E. Application of a new multinomial phase II stopping rule using response and early progression Journal of Clinical Oncology. 19: 785-791. PMID 11157032 DOI: 10.1200/Jco.2001.19.3.785 |
0.347 |
|
| 2001 |
Giaccone G, Shepherd F, Debruyne C, Hirsh V, Smylie M, Rubin S, Martins H, Lamont A, Krzakowski M, Zee B. Final results of a double-blind placebo-controlled study of adjuvant marimastat in small cell lung cancer (SCLC) patients responding to standard therapy European Journal of Cancer. 37. DOI: 10.1016/S0959-8049(01)81047-9 |
0.313 |
|
| 2000 |
Yeo W, Chan PKS, Zhong S, Ho WM, Steinberg JL, Tam JS, Hui P, Leung NWY, Zee B, Johnson PJ. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors Journal of Medical Virology. 62: 299-307. PMID 11055239 DOI: 10.1002/1096-9071(200011)62:3<299::Aid-Jmv1>3.0.Co;2-0 |
0.315 |
|
| 2000 |
Mok TSK, Zee B, Chan ATC, Yeo W, Yang WT, Yim A, Leung SF, Nguyen B, Leung TWT, Johnson P. A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma Cancer. 89: 543-550. PMID 10931453 DOI: 10.1002/1097-0142(20000801)89:3<543::Aid-Cncr9>3.0.Co;2-V |
0.379 |
|
| 2000 |
Piccart MJ, Bertelsen K, James K, Cassidy J, Mangioni C, Simonsen E, Stuart G, Kaye S, Vergote I, Blom R, Grimshaw R, Atkinson RJ, Swenerton KD, Trope C, Nardi M, ... ... Zee B, et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. Journal of the National Cancer Institute. 92: 699-708. PMID 10793106 DOI: 10.1093/Jnci/92.9.699 |
0.415 |
|
| 1999 |
Murray N, Livingston RB, Shepherd FA, James K, Zee B, Langleben A, Kraut M, Bearden J, Goodwin JW, Grafton C, Turrisi A, Walde D, Croft H, Osoba D, Ottaway J, et al. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17: 2300-8. PMID 10561291 DOI: 10.1200/Jco.1999.17.8.2300 |
0.34 |
|
| 1999 |
Zee B, Melnychuk D, Dancey J, Eisenhauer E. Multinomial phase II cancer trials incorporating response and early progression Journal of Biopharmaceutical Statistics. 9: 351-363. PMID 10379698 DOI: 10.1081/Bip-100101181 |
0.34 |
|
| 1998 |
Lévy E, Piedbois P, Buyse M, Pignon JP, Rougier P, Ryan L, Hansen R, Zee B, Weinerman B, Pater J, Leichman C, Macdonald J, Benedetti J, Lokich J, et al. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 3537-41. PMID 9817272 DOI: 10.1200/Jco.1998.16.11.3537 |
0.372 |
|
| 1998 |
Zee B, Cole B, Li T, Browman G, James K, Johnston D, Sugano D, Pater J. Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma Journal of Clinical Oncology. 16: 2834-2839. PMID 9704736 DOI: 10.1200/Jco.1998.16.8.2834 |
0.35 |
|
| 1998 |
Osoba D, Zee B. Completion rates in health-related quality-of-life assessment: Approach of the National Cancer Institute of Canada Clinical Trials Group Statistics in Medicine. 17: 603-612. PMID 9549809 DOI: 10.1002/(Sici)1097-0258(19980315/15)17:5/7<603::Aid-Sim807>3.0.Co;2-D |
0.356 |
|
| 1998 |
Latreille J, Pater J, Johnston D, Laberge F, Stewart D, Rusthoven J, Hoskins P, Findlay B, McMurtrie E, Yelle L, Williams C, Walde D, Ernst S, Dhaliwal H, Warr D, ... ... Zee B, et al. Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 1174-8. PMID 9508205 DOI: 10.1200/Jco.1998.16.3.1174 |
0.327 |
|
| 1998 |
Piedbois P, Rougier P, Buyse M, Pignon J, Ryan L, Hansen R, Zee B, Weinerman B, Pater J, Leichman C, Macdonald J, Benedetti J, Lokich J, Fryer J, et al. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 301-8. PMID 9440757 DOI: 10.1200/Jco.1998.16.1.301 |
0.369 |
|
| 1997 |
Osoba D, Zee B, Warr D, Latreille J, Kaizer L, Pater J. Effect of postchemotherapy nausea and vomiting on health-related quality of life Supportive Care in Cancer. 5: 307-313. PMID 9257427 DOI: 10.1007/S005200050078 |
0.339 |
|
| 1997 |
Osoba D, Zee B, Pater J, Warr D, Latreille J, Kaizer L. Determinants of postchemotherapy nausea and vomiting in patients with cancer Journal of Clinical Oncology. 15: 116-123. PMID 8996132 DOI: 10.1200/Jco.1997.15.1.116 |
0.355 |
|
| 1997 |
Roche K, Paul N, Walker H, Zee B, Smuck B, Hiatt M, Britain M. 04 Measuring workload of cancer clinical trials: A multi-centre study by the clinical research associates (CRA) committee of the national cancer institute of Canada clinical trials group (NCIC CTG) Controlled Clinical Trials. 18. DOI: 10.1016/S0197-2456(97)90989-2 |
0.32 |
|
| 1996 |
Coppin CM, Gospodarowicz MK, James K, Tannock IF, Zee B, Carson J, Pater J, Sullivan LD. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation Journal of Clinical Oncology. 14: 2901-2907. PMID 8918486 DOI: 10.1200/Jco.1996.14.11.2901 |
0.384 |
|
| 1996 |
Rusthoven JJ, Quirt IC, Iscoe NA, McCulloch PB, James KW, Lohmann RC, Jensen J, Burdette-Radoux S, Bodurtha AJ, Silver HK, Verma S, Armitage GR, Zee B, Bennett K. Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 14: 2083-90. PMID 8683240 DOI: 10.1200/Jco.1996.14.7.2083 |
0.373 |
|
| 1996 |
Siu LL, Shepherd FA, Murray N, Feld R, Pater J, Zee B. Influence of age on the treatment of limited-stage small-cell lung cancer Journal of Clinical Oncology. 14: 821-828. PMID 8622030 DOI: 10.1200/Jco.1996.14.3.821 |
0.368 |
|
| 1996 |
Sterns EE, Zee B, SenGupta S, Saunders FW. Thermography. Its relation to pathologic characteristics, vascularity, proliferation rate, and survival of patients with invasive ductal carcinoma of the breast. Cancer. 77: 1324-8. PMID 8608510 DOI: 10.1002/(Sici)1097-0142(19960401)77:7<1324::Aid-Cncr15>3.0.Co;2-3 |
0.314 |
|
| 1994 |
Pater J, Slamet L, Zee B, Osoba D, Warr D, Rusthoven J. Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting Supportive Care in Cancer. 2: 161-166. PMID 8032701 DOI: 10.1007/Bf00417474 |
0.364 |
|
| 1993 |
Brundage MD, Pater JL, Zee B. Assessing the reliability of two toxicity scales: Implications for interpreting toxicity data Journal of the National Cancer Institute. 85: 1138-1148. PMID 8320743 DOI: 10.1093/Jnci/85.14.1138 |
0.321 |
|
| Show low-probability matches. |